Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data

BackgroundThe effectiveness of combining immune checkpoint inhibitors (ICIs) with chemotherapy in treating non-small cell lung cancers (NSCLCs) with BRAF mutations has not been sufficiently explored.MethodsWe compiled data from 306 NSCLC patients with identified BRAF mutations. We looked at efficacy...

Full description

Bibliographic Details
Main Authors: Ningning Yan, Huixian Zhang, Sanxing Guo, Ziheng Zhang, Yingchun Xu, Liang Xu, Xingya Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
immune checkpoint inhibitors
BRAF
NSCLC
programmed death-ligand 1
serine/threonine kinase
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1353491/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1353491/full

Similar Items